Novo Nordisk locks horns with Pfizer
Digest more
The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.
Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...
Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...
Two of the world’s largest pharmaceutical companies, Pfizer (New York, US) and Roche (Basel, Switzerland), have unveiled more ...
Zacks Investment Research on MSN
Earnings Preview: Pfizer (PFE) Q3 Earnings Expected to Decline
Pfizer (PFE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback